CITF Research Results

CITF Research Results2023-10-27T10:53:53-04:00

Recent blood donor data suggest that Canadians still remain vulnerable to SARS-CoV-2 infection

Blood donation organizations to provide important assessment of how long immunity lasts NEWS RELEASE MONTREAL, May 27, 2021 — Results from the latest Canadian Blood Services and Héma-Québec studies, which together cover all 10 provinces, confirm that from coast-to-coast, Canada’s overall levels of seroprevalence due to SARS-CoV-2 infection remained very low earlier this year, as the roll-out of vaccines started ramping up. [...]

New Canada-Wide Research to Study Mixing-and-Matching COVID-19 vaccines

The Government of Canada, through the COVID-19 Immunity Task Force (CITF) and the Vaccine Surveillance Reference Group (VSRG), is supporting a new nation-wide study that will look at the effects of ‘mixing-and-matching’ approved COVID-19 vaccines in adults. Approximately $4.8 million is being provided for this study, which will assess the safety and effectiveness of using two different COVID-19 vaccines for the first and second dose. The project will also study the effects of increasing the interval between doses.

May 20, 2021|Media Releases, Vaccine surveillance|

Preliminary results suggest nearly 6% of Montreal children tested from October to April had antibodies to SARS-CoV-2

Preliminary results from a study underway in Montreal shed important light on the extent to which 2 to 17 years-old have had COVID-19 between last October 2020 and this April 2021. As an overall average, 5.8% of participating children were found to have antibodies to SARS-CoV-2, the virus that causes COVID-19.

May 18, 2021|Media Releases, Pediatrics|
Go to Top